Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity

NCT06782139 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Obesity and Type 2 Diabetes

Interventions

DRUG: Enavogliflozin
DRUG: Placebo

Sponsor

Korea University Anam Hospital

Collaborators

[object Object]